Hypoglycemic Agents
Research News and Information

Saturday, November 07, 2009

Three-year efficacy of complex insulin regimens in type 2 diabetes.

20 Oct 2009 BACKGROUND: Evidence supporting the addition of specific insulin regimens to oral therapy in patients with type 2 diabetes mellitus is limited. METHODS: In this 3-year open-label, multicenter trial, we evaluated 708 patients who had suboptimal ... Read more...

Effect of pyruvate, lactate and insulin on ATP supply and demand in unpaced perfused rat heart.

10 Oct 2009 Mitochondrial respiration/oxidative phosphorylation is the main source of energy, in the form of ATP, in the heart under physiological conditions. Different respiratory substrates were used in various experiments during heart perfusion: glucose, ... Read more...

Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada.

5 Oct 2009 CONTEXT: National public insurance for drugs is often based on evidence of comparative effectiveness and cost-effectiveness. This study describes how that evidence has been used across 3 jurisdictions (Australia, Canada, and Britain) that have been ... Read more...

Latest indexed articles for 'Hypoglycemic Agents'

These are the very latest articles for this heading:

• Obesity and survival among patients with pancreatic cancer. 26 Oct 2009
• Three-year efficacy of complex insulin regimens in type 2 diabetes. 20 Oct 2009
• Optimal insulin treatment in type 2 diabetes. 20 Oct 2009
• Variation in event rates in trials of patients with type 2 diabetes. 19 Oct 2009
• Police find range of drugs after trawling bins used by Tour de France cyclists. 11 Oct 2009
• Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors. 10 Oct 2009
• Effect of pyruvate, lactate and insulin on ATP supply and demand in unpaced perfused rat heart. 10 Oct 2009
• Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada. 5 Oct 2009
• Diabetes and the public's health. Oct 2009
• Leukocytoclastic vasculitis associated with insulin aspart in a patient with type 2 diabetes. 29 Sep 2009
• Synthetic protection short interfering RNA screen reveals glyburide as a novel radioprotector. 29 Sep 2009
• Early Origins of polycystic ovary syndrome: hypotheses may change without notice. 29 Sep 2009
• Hepatic drug transporters, old and new: pharmacogenomics, drug response, and clinical relevance. 29 Sep 2009
• Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. 29 Sep 2009
• Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. 29 Sep 2009
• Therapies for type 2 diabetes and coronary artery disease. 29 Sep 2009
• Gestational diabetes--whom do we treat? 29 Sep 2009
• A multicenter, randomized trial of treatment for mild gestational diabetes. 29 Sep 2009
• Comparison of incidence of acute myocardial infarction in patients with type 2 diabetes mellitus following initiation of neutral protamine Hagedorn insulin versus insulin glargine. 29 Sep 2009
• Rosiglitazone and pioglitazone. Beware fractures. 27 Sep 2009

See a longer list of these articles.

Technical information about 'Hypoglycemic Agents'

Definition: Agents which lower the blood glucose level.

Registry Number: 0

Descriptor UI: D007004

Alternative terms: Hypoglycemic Agents; Agents, Hypoglycemic; Hypoglycemics; Hypoglycemic Drugs; Drugs, Hypoglycemic; Antidiabetics; Antidiabetic Drugs; Drugs, Antidiabetic; Antidiabetic Agents; Agents, Antidiabetic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.696.422;

Online Note: use HYPOGLYCEMIC AGENTS to search ANTIDIABETICS 1966-75

History Note: 76; was NON MESH 1975, was see under ANTIDIABETICS 1968-74; ANTIDIABETICS was heading 1963-75